Cargando…

The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension

Pulmonary hypertension (PH) is a progressive cardiovascular disorder in which local vascular inflammation leads to increased pulmonary vascular remodeling and ultimately to right heart failure. The HDAC inhibitor butyrate, a product of microbial fermentation, is protective in inflammatory intestinal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karoor, Vijaya, Strassheim, Derek, Sullivan, Timothy, Verin, Alexander, Umapathy, Nagavedi S., Dempsey, Edward C., Frank, Daniel N., Stenmark, Kurt R., Gerasimovskaya, Evgenia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467617/ https://www.ncbi.nlm.nih.gov/pubmed/34576081 http://dx.doi.org/10.3390/ijms22189916

Ejemplares similares

A current view of G protein-coupled receptor - mediated signaling in pulmonary hypertension: finding opportunities for therapeutic intervention
por: Strassheim, Derek, et al.
Publicado: (2018)

Role of Inflammatory Cell Subtypes in Heart Failure
por: Strassheim, Derek, et al.
Publicado: (2019)

P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases
por: Strassheim, Derek, et al.
Publicado: (2020)

RhoGTPase in Vascular Disease
por: Strassheim, Derek, et al.
Publicado: (2019)

c-Jun, Foxo3a, and c-Myc Transcription Factors are Key Regulators of ATP-Mediated Angiogenic Responses in Pulmonary Artery Vasa Vasorum Endothelial Cells †
por: Strassheim, Derek, et al.
Publicado: (2020)

Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases
por: Strassheim, Derek, et al.
Publicado: (2021)

Adenosine A1 Receptors Promote Vasa Vasorum Endothelial Cell Barrier Integrity via G(i) and Akt-Dependent Actin Cytoskeleton Remodeling
por: Siddaramappa Umapathy, Nagavedi, et al.
Publicado: (2013)

Correction: Adenosine A1 Receptors Promote Vasa Vasorum Endothelial Cell Barrier Integrity via G(i) and Akt-Dependent Actin Cytoskeleton Remodeling
por: Siddaramappa Umapathy, Nagavedi, et al.
Publicado: (2013)

Glycolysis and oxidative phosphorylation are essential for purinergic receptor-mediated angiogenic responses in vasa vasorum endothelial cells
por: Lapel, Martin, et al.
Publicado: (2016)

Evidence supporting a role for circulating macrophages in the regression of vascular remodeling following sub-chronic exposure to hemoglobin plus hypoxia
por: Karoor, Vijaya, et al.
Publicado: (2021)

Impaired vascular function with age and RhoGTPase
por: Dempsey, Edward, et al.
Publicado: (2020)

Vascular remodeling 2018: the updates
por: Gerasimovskaya, Evgenia, et al.
Publicado: (2019)

Extracellular ATP is a pro-angiogenic factor for pulmonary artery vasa vasorum endothelial cells
por: Gerasimovskaya, Evgenia V., et al.
Publicado: (2007)

P2Y receptors as regulators of lung endothelial barrier integrity
por: Zemskov, Evgeny, et al.
Publicado: (2011)

Progenitor cells in pulmonary vascular remodeling
por: Yeager, Michael E., et al.
Publicado: (2011)

Editorial: Molecular mechanisms of lung endothelial permeability
por: Parinandi, Narasimham, et al.
Publicado: (2022)

JNK2 regulates vascular remodeling in pulmonary hypertension
por: Das, Mita, et al.
Publicado: (2018)

Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice
por: Paddenberg, Renate, et al.
Publicado: (2007)

Hemoglobin induced cell trauma indirectly influences endothelial TLR9 activity resulting in pulmonary vascular smooth muscle cell activation
por: Loomis, Zoe, et al.
Publicado: (2017)

Astragaloside IV attenuates hypoxia-induced pulmonary vascular remodeling via the Notch signaling pathway
por: Yao, Jiamei, et al.
Publicado: (2021)

Astragaloside IV attenuates hypoxia-induced pulmonary vascular remodeling via the Notch signaling pathway
por: Yao, Jiamei, et al.
Publicado: (2022)

Inflammation, immunity, and vascular remodeling in pulmonary hypertension; Evidence for complement involvement?
por: Frid, Maria G., et al.
Publicado: (2020)

Correction: Hemoglobin induced cell trauma indirectly influences endothelial TLR9 activity resulting in pulmonary vascular smooth muscle cell activation
por: Loomis, Zoe, et al.
Publicado: (2017)

Protective effect of Growth Hormone-Releasing Hormone agonist in bacterial toxin-induced pulmonary barrier dysfunction
por: Czikora, Istvan, et al.
Publicado: (2014)

Complementary effects of extracellular nucleotides and platelet-derived extracts on angiogenesis of vasa vasorum endothelial cells in vitro and subcutaneous Matrigel plugs in vivo
por: Roedersheimer, Mark, et al.
Publicado: (2011)

Hypoxia induces endothelial-mesenchymal transition in pulmonary vascular remodeling
por: Zhang, Bo, et al.
Publicado: (2018)

The role of macrophages in right ventricular remodeling in experimental pulmonary hypertension
por: Gu, Sue, et al.
Publicado: (2022)

Antagonism of Stem Cell Factor/c-kit Signaling Attenuates Neonatal Chronic Hypoxia-Induced Pulmonary Vascular Remodeling
por: Young, Karen C, et al.
Publicado: (2015)

Nanoparticle endothelial delivery of PGC-1α attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling
por: Cai, Dunpeng, et al.
Publicado: (2022)

Hypoxia-induced pulmonary hypertension and chronic lung disease: caveolin-1 dysfunction an important underlying feature
por: Huang, Jing, et al.
Publicado: (2019)

Distinct responses to hypoxia in subpopulations of distal pulmonary artery cells contribute to pulmonary vascular remodeling in emphysema
por: Howard, L. S., et al.
Publicado: (2012)

Immunoglobulin-driven Complement Activation Regulates Proinflammatory Remodeling in Pulmonary Hypertension
por: Frid, Maria G., et al.
Publicado: (2020)

Melatonin Attenuates Dasatinib-Aggravated Hypoxic Pulmonary Hypertension via Inhibiting Pulmonary Vascular Remodeling
por: Wang, Rui, et al.
Publicado: (2022)

Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement
por: Stenmark, Kurt R., et al.
Publicado: (2021)

Butyrate: Connecting the gut-lung axis to the management of pulmonary disorders
por: Corrêa, Renan Oliveira, et al.
Publicado: (2022)

Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
por: Boehm, Mario, et al.
Publicado: (2018)

Formononetin attenuates monocrotaline-induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats
por: Cai, Changhong, et al.
Publicado: (2019)

Elevation of iron storage in humans attenuates the pulmonary vascular response to hypoxia
por: Bart, Nicole K., et al.
Publicado: (2016)

Andrographolide Attenuates Established Pulmonary Hypertension via Rescue of Vascular Remodeling
por: Nie, Xiaowei, et al.
Publicado: (2021)

Key Role of ROS in the Process of 15-Lipoxygenase/15-Hydroxyeicosatetraenoiccid-Induced Pulmonary Vascular Remodeling in Hypoxia Pulmonary Hypertension
por: Li, Qian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d12v6l60d6e8plj75r86je1otr